ApiFix
Meytal Bork is a Clinical Trial Manager at ApiFix since May 2022, and previously served as a Medical Device Engineer at Mitralix Ltd. from January 2019 to December 2021. Prior experience includes a role as a Research Assistant at both the Technion - Israel Institute of Technology and Bonn-Rhein-Sieg University of Applied Sciences, as well as time as a Chemistry Tutor at the Center for Educational Technology. From July 2014 to August 2015, Meytal held the position of Programme Director at the Galilee International Management Institute, and from August 2010 to April 2014, worked as a Research Team Leader and Analyst with the Israel Defense Forces' Military Intelligence. Meytal Bork's academic credentials include an MBA and a B.Sc in Materials Engineering and Biology from the Technion - Israel Institute of Technology, obtained between 2015 and 2022.
This person is not in any teams
ApiFix
ApiFix minimally invasive scoliosis correction system is aimed to treat patients suffering from Adolescent Idiopathic Scoliosis (AIS) that are classified as Lenke Type 1 or and Type 5, having with a Cobb angle from 35 to 55 degrees.Unlike the traditional scoliosis correction operation that tries attempts to fix the deformity in one aggressiveand complex operation, the ApiFix system is based on a minimal surgical intervention and a correction process that spans over several months, with the aid of unique physical therapy.